Glycopyrrolate and Ancef drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Glycopyrrolate and Ancef. Common interactions include cough among females and renal failure among males.
The phase IV clinical study analyzes what interactions people who take Glycopyrrolate and Ancef have. It is created by eHealthMe based on reports of 25 people who take Glycopyrrolate and Ancef from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
25 people who take Glycopyrrolate and Ancef together, and have interactions are studied.
What is Glycopyrrolate?
Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 3,776 Glycopyrrolate users for its effectiveness, alternative drugs and more.
What is Ancef?
Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,174 Ancef users for its effectiveness, alternative drugs and more.
Number of Glycopyrrolate and Ancef reports submitted per year:

Common Glycopyrrolate and Ancef drug interactions by gender *:
female:
- Cough
- Death
- Diarrhoea
- Dry skin
- End-tidal co2 decreased
- Erythema
- Hair colour changes
- Infection
- Mental disorder
- Nasal congestion
male:
- Renal failure
- Anhedonia
- Renal injury
- Back pain
- Complications of transplanted kidney
- Conjunctivitis
- Dehydration
- Diarrhoea
- Hyperglycaemia
- Hypervolaemia
Common Glycopyrrolate and Ancef drug interactions by age *:
0-1:
- Bacterial infection
- Blood chloride increased
- Blood creatinine decreased
- Blood culture positive
- Bradycardia
- Breath holding
- C-reactive protein increased
- Constipation
- Cough
- Diarrhoea
2-9:
n/a
10-19:
n/a
20-29:
- Pulmonary embolism
30-39:
- Cholecystitis chronic
- Pulmonary embolism
40-49:
- Cholelithiasis
- Compulsive shopping
- Hypoventilation
- Injury
- Mental disorder
- Obsessive-compulsive disorder
- Panic disorder
- Pulmonary embolism
- Unresponsive to stimuli
- Bladder spasm
50-59:
- Acidosis
- Alopecia areata
- Alopecia totalis
- Amylase increased
- Anaemia
- Back pain
- Blood pressure decreased
- Bradycardia
- Cardiac arrest
- Clostridium colitis
60+:
- Renal failure
- Injury
- Complications of transplanted kidney
- Conjunctivitis
- Cough
- Dehydration
- Diarrhoea
- Hyperkalaemia
- Hypervolaemia
- Hypotension
Common conditions people have *:
- Post-Traumatic Stress Disorder: 3 people, 12.00%
- Pain: 2 people, 8.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.00%
- Anaesthesia Reversal: 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Glycopyrrolate and Ancef?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Glycopyrrolate (3,776 reports)
- Ancef (3,174 reports)
Browse all drug interactions of Glycopyrrolate and Ancef:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Glycopyrrolate side effects:
- Breathing difficulty: 568 reports
- Cough: 401 reports
- Wheezing (a high-pitched whistling sound made while you breath): 281 reports
- Pneumonia: 272 reports
- Chest pain: 247 reports
- Drug ineffective: 246 reports
- High blood pressure: 244 reports
- Weight decreased: 224 reports
- Malaise (a feeling of general discomfort or uneasiness): 218 reports
- Fever: 205 reports
Browse all side effects of Glycopyrrolate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ancef side effects:
- Pain: 1,004 reports
- Stress and anxiety: 853 reports
- Acute kidney failure: 779 reports
Browse all side effects of Ancef:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Glycopyrrolate interactions:
- Glycopyrrolate and Propofol: 694 reports
- Glycopyrrolate and Ondansetron: 513 reports
- Glycopyrrolate and Fentanyl: 504 reports
- Glycopyrrolate and Prednisone: 454 reports
- Glycopyrrolate and Albuterol: 380 reports
- Glycopyrrolate and Aspirin: 348 reports
- Glycopyrrolate and Morphine: 324 reports
- Glycopyrrolate and Omeprazole: 284 reports
- Glycopyrrolate and Pantoprazole: 271 reports
- Glycopyrrolate and Furosemide: 262 reports
Browse all interactions between Glycopyrrolate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ancef interactions:
- Ancef and Heparin: 1,000 reports
- Ancef and Trasylol: 756 reports
- Ancef and Lasix: 742 reports
- Ancef and Versed: 706 reports
- Ancef and Fentanyl: 590 reports
- Ancef and Morphine: 580 reports
- Ancef and Aspirin: 471 reports
- Ancef and Protamine sulfate: 451 reports
- Ancef and Tylenol: 401 reports
- Ancef and Zofran: 389 reports
Browse all interactions between Ancef and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate and cefazolin sodium (the active ingredients of Glycopyrrolate and Ancef, respectively), and Glycopyrrolate and Ancef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glycopyrrolate and Ancef.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nasalcrom vs. Patanase - 3 seconds ago
- Beyaz vs. Norethidrone - 7 seconds ago
- Magnesium Sulfate and Combivent drug interaction - 58 seconds ago
- Klor-Con and Combivent drug interaction - a minute ago
- Tylenol W/ Codeine vs. Diclofenac Sodium - a minute ago
- Methocarbamol and Combivent drug interaction - a minute ago
- Asmanex Twisthaler and Combivent drug interaction - a minute ago
- Combivent and Reglan drug interaction - a minute ago
- Prilosec and Lipoic Acid drug interaction - a minute ago
- Combivent and Forteo drug interaction - a minute ago